Standard
Development of a core outcome set for basal cell carcinoma. / Schlessinger, Daniel I.; Reynolds, Kelly A.; Dirr, McKenzie A.; Ibrahim, Sarah A.; Yanes, Arianna F.; Lazaroff, Jake M.; Godinez-Puig, Victoria; Chen, Brian R.; Kurta, Anastasia O.; Cotseones, Jill K.; Chiren, Sarah G.; Furlan, Karina C.; Iyengar, Sanjana; Behshad, Ramona; DeHoratius, Danielle M.; Denes, Pablo; Drucker, Aaron M.; Dzubow, Leonard M.; Etzkorn, Jeremy R.; Harwood, Catherine A.; Kim, John Y.S.; Lawrence, Naomi; Lee, Erica H.; Lissner, Gary S.; Marghoob, Ashfaq A.; Matin, Rubeta N.; Mattox, Adam R.; Mittal, Bharat B.; Thomas, J. Regan; Zhou, Xiaolong Alan; Zloty, David; Schmitt, Jochen; Kirkham, Jamie J.; Armstrong, April W.; Basset-Seguin, Nicole; Billingsley, Elizabeth M.; Bordeaux, Jeremy S.; Brewer, Jerry; Brown, Marc; Brown, Mariah; Collins, Scott A.B.; Fargnoli, Maria Concetta; De Azevedo, Sergio Jobim; Dummer, Reinhard; Eggermont, Alexander; Goldman, Glenn D.; Haedersdal, Merete; Hale, Elizabeth K.; Hanlon, Allison; Harms, Kelly L.; Huang, Conway C.; Hurst, Eva A.; In, Gino K.; Kelleners-Smeets, Nicole; Kheterpal, Meenal; Leshin, Barry; Mcdonald, Michel; Miller, Stanley J.; Miller, Alexander; Mostow, Eliot N.; Trakatelli, Myrto; Nehal, Kishwer S.; Ratner, Desiree; Rogers, Howard; Sarin, Kavita Y.; Soon, Seaver L.; Stasko, Thomas; Storrs, Paul A.; Tagliaferri, Luca; Vidimos, Allison T.; Wong, Sandra L.; Yu, Siegrid S.; Zalaudek, Iris; Zeitouni, Nathalie C.; Zitelli, John A.; Poon, Emily; Sobanko, Joseph F.; Cartee, Todd V.; Maher, Ian A.; Alam, Murad.
I:
Journal of the American Academy of Dermatology, Bind 87, Nr. 3, 2022, s. 573-581.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Schlessinger, DI, Reynolds, KA, Dirr, MA, Ibrahim, SA, Yanes, AF, Lazaroff, JM, Godinez-Puig, V, Chen, BR, Kurta, AO, Cotseones, JK, Chiren, SG, Furlan, KC, Iyengar, S, Behshad, R, DeHoratius, DM, Denes, P, Drucker, AM, Dzubow, LM, Etzkorn, JR, Harwood, CA, Kim, JYS, Lawrence, N, Lee, EH, Lissner, GS, Marghoob, AA, Matin, RN, Mattox, AR, Mittal, BB, Thomas, JR, Zhou, XA, Zloty, D, Schmitt, J, Kirkham, JJ, Armstrong, AW, Basset-Seguin, N, Billingsley, EM, Bordeaux, JS, Brewer, J, Brown, M, Brown, M, Collins, SAB, Fargnoli, MC, De Azevedo, SJ, Dummer, R, Eggermont, A, Goldman, GD
, Haedersdal, M, Hale, EK, Hanlon, A, Harms, KL, Huang, CC, Hurst, EA, In, GK, Kelleners-Smeets, N, Kheterpal, M, Leshin, B, Mcdonald, M, Miller, SJ, Miller, A, Mostow, EN, Trakatelli, M, Nehal, KS, Ratner, D, Rogers, H, Sarin, KY, Soon, SL, Stasko, T, Storrs, PA, Tagliaferri, L, Vidimos, AT, Wong, SL, Yu, SS, Zalaudek, I, Zeitouni, NC, Zitelli, JA, Poon, E, Sobanko, JF, Cartee, TV, Maher, IA & Alam, M 2022, '
Development of a core outcome set for basal cell carcinoma',
Journal of the American Academy of Dermatology, bind 87, nr. 3, s. 573-581.
https://doi.org/10.1016/j.jaad.2022.04.059APA
Schlessinger, D. I., Reynolds, K. A., Dirr, M. A., Ibrahim, S. A., Yanes, A. F., Lazaroff, J. M., Godinez-Puig, V., Chen, B. R., Kurta, A. O., Cotseones, J. K., Chiren, S. G., Furlan, K. C., Iyengar, S., Behshad, R., DeHoratius, D. M., Denes, P., Drucker, A. M., Dzubow, L. M., Etzkorn, J. R., ... Alam, M. (2022).
Development of a core outcome set for basal cell carcinoma.
Journal of the American Academy of Dermatology,
87(3), 573-581.
https://doi.org/10.1016/j.jaad.2022.04.059Vancouver
Schlessinger DI, Reynolds KA, Dirr MA, Ibrahim SA, Yanes AF, Lazaroff JM o.a.
Development of a core outcome set for basal cell carcinoma.
Journal of the American Academy of Dermatology. 2022;87(3):573-581.
https://doi.org/10.1016/j.jaad.2022.04.059Author
Schlessinger, Daniel I. ; Reynolds, Kelly A. ; Dirr, McKenzie A. ; Ibrahim, Sarah A. ; Yanes, Arianna F. ; Lazaroff, Jake M. ; Godinez-Puig, Victoria ; Chen, Brian R. ; Kurta, Anastasia O. ; Cotseones, Jill K. ; Chiren, Sarah G. ; Furlan, Karina C. ; Iyengar, Sanjana ; Behshad, Ramona ; DeHoratius, Danielle M. ; Denes, Pablo ; Drucker, Aaron M. ; Dzubow, Leonard M. ; Etzkorn, Jeremy R. ; Harwood, Catherine A. ; Kim, John Y.S. ; Lawrence, Naomi ; Lee, Erica H. ; Lissner, Gary S. ; Marghoob, Ashfaq A. ; Matin, Rubeta N. ; Mattox, Adam R. ; Mittal, Bharat B. ; Thomas, J. Regan ; Zhou, Xiaolong Alan ; Zloty, David ; Schmitt, Jochen ; Kirkham, Jamie J. ; Armstrong, April W. ; Basset-Seguin, Nicole ; Billingsley, Elizabeth M. ; Bordeaux, Jeremy S. ; Brewer, Jerry ; Brown, Marc ; Brown, Mariah ; Collins, Scott A.B. ; Fargnoli, Maria Concetta ; De Azevedo, Sergio Jobim ; Dummer, Reinhard ; Eggermont, Alexander ; Goldman, Glenn D. ; Haedersdal, Merete ; Hale, Elizabeth K. ; Hanlon, Allison ; Harms, Kelly L. ; Huang, Conway C. ; Hurst, Eva A. ; In, Gino K. ; Kelleners-Smeets, Nicole ; Kheterpal, Meenal ; Leshin, Barry ; Mcdonald, Michel ; Miller, Stanley J. ; Miller, Alexander ; Mostow, Eliot N. ; Trakatelli, Myrto ; Nehal, Kishwer S. ; Ratner, Desiree ; Rogers, Howard ; Sarin, Kavita Y. ; Soon, Seaver L. ; Stasko, Thomas ; Storrs, Paul A. ; Tagliaferri, Luca ; Vidimos, Allison T. ; Wong, Sandra L. ; Yu, Siegrid S. ; Zalaudek, Iris ; Zeitouni, Nathalie C. ; Zitelli, John A. ; Poon, Emily ; Sobanko, Joseph F. ; Cartee, Todd V. ; Maher, Ian A. ; Alam, Murad. / Development of a core outcome set for basal cell carcinoma. I: Journal of the American Academy of Dermatology. 2022 ; Bind 87, Nr. 3. s. 573-581.
Bibtex
@article{b1ab05bb7b47414891e8c786c2a5ac70,
title = "Development of a core outcome set for basal cell carcinoma",
abstract = "Background: There is variation in the outcomes reported in clinical studies of basal cell carcinoma. This can prevent effective meta-analyses from answering important clinical questions. Objective: To identify a recommended minimum set of core outcomes for basal cell carcinoma clinical trials. Methods: Patient and professional Delphi process to cull a long list, culminating in a consensus meeting. To be provisionally accepted, outcomes needed to be deemed important (score, 7-9, with 9 being the maximum) by 70% of each stakeholder group. Results: Two hundred thirty-five candidate outcomes identified via a systematic literature review and survey of key stakeholders were reduced to 74 that were rated by 100 health care professionals and patients in 2 Delphi rounds. Twenty-seven outcomes were provisionally accepted. The final core set of 5 agreed-upon outcomes after the consensus meeting included complete response; persistent or serious adverse events; recurrence-free survival; quality of life; and patient satisfaction, including cosmetic outcome. Limitations: English-speaking patients and professionals rated outcomes extracted from English language studies. Conclusion: A core outcome set for basal cell carcinoma has been developed. The use of relevant measures may improve the utility of clinical research and the quality of therapeutic guidance available to clinicians.",
keywords = "basal cell carcinoma, core, measure, outcome, set, skin cancer",
author = "Schlessinger, {Daniel I.} and Reynolds, {Kelly A.} and Dirr, {McKenzie A.} and Ibrahim, {Sarah A.} and Yanes, {Arianna F.} and Lazaroff, {Jake M.} and Victoria Godinez-Puig and Chen, {Brian R.} and Kurta, {Anastasia O.} and Cotseones, {Jill K.} and Chiren, {Sarah G.} and Furlan, {Karina C.} and Sanjana Iyengar and Ramona Behshad and DeHoratius, {Danielle M.} and Pablo Denes and Drucker, {Aaron M.} and Dzubow, {Leonard M.} and Etzkorn, {Jeremy R.} and Harwood, {Catherine A.} and Kim, {John Y.S.} and Naomi Lawrence and Lee, {Erica H.} and Lissner, {Gary S.} and Marghoob, {Ashfaq A.} and Matin, {Rubeta N.} and Mattox, {Adam R.} and Mittal, {Bharat B.} and Thomas, {J. Regan} and Zhou, {Xiaolong Alan} and David Zloty and Jochen Schmitt and Kirkham, {Jamie J.} and Armstrong, {April W.} and Nicole Basset-Seguin and Billingsley, {Elizabeth M.} and Bordeaux, {Jeremy S.} and Jerry Brewer and Marc Brown and Mariah Brown and Collins, {Scott A.B.} and Fargnoli, {Maria Concetta} and {De Azevedo}, {Sergio Jobim} and Reinhard Dummer and Alexander Eggermont and Goldman, {Glenn D.} and Merete Haedersdal and Hale, {Elizabeth K.} and Allison Hanlon and Harms, {Kelly L.} and Huang, {Conway C.} and Hurst, {Eva A.} and In, {Gino K.} and Nicole Kelleners-Smeets and Meenal Kheterpal and Barry Leshin and Michel Mcdonald and Miller, {Stanley J.} and Alexander Miller and Mostow, {Eliot N.} and Myrto Trakatelli and Nehal, {Kishwer S.} and Desiree Ratner and Howard Rogers and Sarin, {Kavita Y.} and Soon, {Seaver L.} and Thomas Stasko and Storrs, {Paul A.} and Luca Tagliaferri and Vidimos, {Allison T.} and Wong, {Sandra L.} and Yu, {Siegrid S.} and Iris Zalaudek and Zeitouni, {Nathalie C.} and Zitelli, {John A.} and Emily Poon and Sobanko, {Joseph F.} and Cartee, {Todd V.} and Maher, {Ian A.} and Murad Alam",
note = "Funding Information: Funding sources: Supported by the Merz Center for Quality and Outcomes Research in Dermatologic Surgery and the IMPROVED (Measurement of Priority Outcome Variables in Dermatologic Surgery) Group . ",
year = "2022",
doi = "10.1016/j.jaad.2022.04.059",
language = "English",
volume = "87",
pages = "573--581",
journal = "American Academy of Dermatology. Journal",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "3",
}
RIS
TY - JOUR
T1 - Development of a core outcome set for basal cell carcinoma
AU - Schlessinger, Daniel I.
AU - Reynolds, Kelly A.
AU - Dirr, McKenzie A.
AU - Ibrahim, Sarah A.
AU - Yanes, Arianna F.
AU - Lazaroff, Jake M.
AU - Godinez-Puig, Victoria
AU - Chen, Brian R.
AU - Kurta, Anastasia O.
AU - Cotseones, Jill K.
AU - Chiren, Sarah G.
AU - Furlan, Karina C.
AU - Iyengar, Sanjana
AU - Behshad, Ramona
AU - DeHoratius, Danielle M.
AU - Denes, Pablo
AU - Drucker, Aaron M.
AU - Dzubow, Leonard M.
AU - Etzkorn, Jeremy R.
AU - Harwood, Catherine A.
AU - Kim, John Y.S.
AU - Lawrence, Naomi
AU - Lee, Erica H.
AU - Lissner, Gary S.
AU - Marghoob, Ashfaq A.
AU - Matin, Rubeta N.
AU - Mattox, Adam R.
AU - Mittal, Bharat B.
AU - Thomas, J. Regan
AU - Zhou, Xiaolong Alan
AU - Zloty, David
AU - Schmitt, Jochen
AU - Kirkham, Jamie J.
AU - Armstrong, April W.
AU - Basset-Seguin, Nicole
AU - Billingsley, Elizabeth M.
AU - Bordeaux, Jeremy S.
AU - Brewer, Jerry
AU - Brown, Marc
AU - Brown, Mariah
AU - Collins, Scott A.B.
AU - Fargnoli, Maria Concetta
AU - De Azevedo, Sergio Jobim
AU - Dummer, Reinhard
AU - Eggermont, Alexander
AU - Goldman, Glenn D.
AU - Haedersdal, Merete
AU - Hale, Elizabeth K.
AU - Hanlon, Allison
AU - Harms, Kelly L.
AU - Huang, Conway C.
AU - Hurst, Eva A.
AU - In, Gino K.
AU - Kelleners-Smeets, Nicole
AU - Kheterpal, Meenal
AU - Leshin, Barry
AU - Mcdonald, Michel
AU - Miller, Stanley J.
AU - Miller, Alexander
AU - Mostow, Eliot N.
AU - Trakatelli, Myrto
AU - Nehal, Kishwer S.
AU - Ratner, Desiree
AU - Rogers, Howard
AU - Sarin, Kavita Y.
AU - Soon, Seaver L.
AU - Stasko, Thomas
AU - Storrs, Paul A.
AU - Tagliaferri, Luca
AU - Vidimos, Allison T.
AU - Wong, Sandra L.
AU - Yu, Siegrid S.
AU - Zalaudek, Iris
AU - Zeitouni, Nathalie C.
AU - Zitelli, John A.
AU - Poon, Emily
AU - Sobanko, Joseph F.
AU - Cartee, Todd V.
AU - Maher, Ian A.
AU - Alam, Murad
N1 - Funding Information:
Funding sources: Supported by the Merz Center for Quality and Outcomes Research in Dermatologic Surgery and the IMPROVED (Measurement of Priority Outcome Variables in Dermatologic Surgery) Group .
PY - 2022
Y1 - 2022
N2 - Background: There is variation in the outcomes reported in clinical studies of basal cell carcinoma. This can prevent effective meta-analyses from answering important clinical questions. Objective: To identify a recommended minimum set of core outcomes for basal cell carcinoma clinical trials. Methods: Patient and professional Delphi process to cull a long list, culminating in a consensus meeting. To be provisionally accepted, outcomes needed to be deemed important (score, 7-9, with 9 being the maximum) by 70% of each stakeholder group. Results: Two hundred thirty-five candidate outcomes identified via a systematic literature review and survey of key stakeholders were reduced to 74 that were rated by 100 health care professionals and patients in 2 Delphi rounds. Twenty-seven outcomes were provisionally accepted. The final core set of 5 agreed-upon outcomes after the consensus meeting included complete response; persistent or serious adverse events; recurrence-free survival; quality of life; and patient satisfaction, including cosmetic outcome. Limitations: English-speaking patients and professionals rated outcomes extracted from English language studies. Conclusion: A core outcome set for basal cell carcinoma has been developed. The use of relevant measures may improve the utility of clinical research and the quality of therapeutic guidance available to clinicians.
AB - Background: There is variation in the outcomes reported in clinical studies of basal cell carcinoma. This can prevent effective meta-analyses from answering important clinical questions. Objective: To identify a recommended minimum set of core outcomes for basal cell carcinoma clinical trials. Methods: Patient and professional Delphi process to cull a long list, culminating in a consensus meeting. To be provisionally accepted, outcomes needed to be deemed important (score, 7-9, with 9 being the maximum) by 70% of each stakeholder group. Results: Two hundred thirty-five candidate outcomes identified via a systematic literature review and survey of key stakeholders were reduced to 74 that were rated by 100 health care professionals and patients in 2 Delphi rounds. Twenty-seven outcomes were provisionally accepted. The final core set of 5 agreed-upon outcomes after the consensus meeting included complete response; persistent or serious adverse events; recurrence-free survival; quality of life; and patient satisfaction, including cosmetic outcome. Limitations: English-speaking patients and professionals rated outcomes extracted from English language studies. Conclusion: A core outcome set for basal cell carcinoma has been developed. The use of relevant measures may improve the utility of clinical research and the quality of therapeutic guidance available to clinicians.
KW - basal cell carcinoma
KW - core
KW - measure
KW - outcome
KW - set
KW - skin cancer
U2 - 10.1016/j.jaad.2022.04.059
DO - 10.1016/j.jaad.2022.04.059
M3 - Journal article
C2 - 35551965
AN - SCOPUS:85132831917
VL - 87
SP - 573
EP - 581
JO - American Academy of Dermatology. Journal
JF - American Academy of Dermatology. Journal
SN - 0190-9622
IS - 3
ER -
